We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Replacement Heart-Conduit Valve Implanted Without Surgery

By HospiMedica International staff writers
Posted on 08 Feb 2010
An innovative transcatheter pulmonary valve (TPV) offers a nonsurgical valve replacement option for patients with congenital heart disease (CHD). More...


The Melody TPV is delivered through a catheter requiring only a small incision, and should benefit children and adults born with a malformation of the pulmonary valve. Deep coaptation of the Melody TPV leaflets provides valve competency across a range of diameters and geometries, and natural venous valve leaflets open and close under minimal pressure for optimal hemodynamics. Sutures at every node of the TPV are designed to enhance valve integrity. The Melody TPV is delivered via the Ensemble transcatheter delivery system, using fluoroscopic guidance. The 22 French delivery catheter offers a low crossing profile, and a balloon-in-balloon deployment enables minor adjustments to facilitate accurate placement. A unique coverage sheath protects the valve during delivery up to the point of deployment.

Similar to other conduits, the Melody TPV does not cure the heart condition and over time may wear and require replacement. But since it is implanted without open heart surgery, it can prop open the poorly functioning conduit and can keep blood flowing in the proper direction, which will allow a patient's conduit to function longer than usual, delaying the need for more invasive open-heart surgery. The Melody TPV and the Ensemble delivery system are products of Medtronic (Minneapolis, MN, USA), and have received U.S. Food and Drug Administration (FDA) approval under a Humanitarian Device Exemption (HDE).

"The Melody Transcatheter Pulmonary Valve is a significant technological breakthrough and offers a reprieve for many patients with congenital heart disease – many of whom are young and will require several heart surgeries over their lifetime,” said pediatric cardiologist William Hellenbrand, M.D., of Columbia University Medical Center (New York, NY, USA). "The Melody valve gives patients with congenital heart disease a new, nonsurgical approach to managing their disease.”

Conduits are surgically implanted valves used to treat patients with congenital heart defects that have narrowed, leaky, or missing pulmonary valves that impede the proper flow of blood from the heart's right ventricle to the pulmonary artery, which then sends the blood on to the lungs for oxygenation.

Related Links:

Medtronic



Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical System
Stealth AXiS
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.